Can I continue using GLP-1 after I hit my weight loss goals
Retatrutide, an experimental weight loss drug that hasnt been submitted for FDA-approval, is being prescribed in weight loss clinics and med spas across the country
This mechanism prevents Cd from entering the cytoplasm, thereby protecting intracellular metabolic activities [22, 23]
According to the Navadhi Global Peptide Therapy Market Strategic Research Report 2026-2031 , India's emergence as both a high-growth demand market (19.89% CAGR) and a biosimilar manufacturing hub creates a unique dual role as GLP-1 costs decline through Indian biosimilar production, the addressable patient population in price-sensitive Asian and African markets will expand dramatically, driving the 21.24% volume CAGR through 2031.
These disturbances are most commonly related to vomiting, diarrhea, and poor oral intake rather than the direct effect of weight loss itself